Editas Medicine (EDIT) Equity Average: 2016-2025
Historic Equity Average for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $16.3 million.
- Editas Medicine's Equity Average fell 91.99% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year decrease of 91.99%. This contributed to the annual value of $241.7 million for FY2024, which is 31.90% down from last year.
- According to the latest figures from Q3 2025, Editas Medicine's Equity Average is $16.3 million, which was down 60.00% from $40.8 million recorded in Q2 2025.
- Over the past 5 years, Editas Medicine's Equity Average peaked at $625.7 million during Q2 2021, and registered a low of $16.3 million during Q3 2025.
- In the last 3 years, Editas Medicine's Equity Average had a median value of $263.2 million in 2024 and averaged $230.2 million.
- As far as peak fluctuations go, Editas Medicine's Equity Average soared by 107.56% in 2021, and later tumbled by 91.99% in 2025.
- Over the past 5 years, Editas Medicine's Equity Average (Quarterly) stood at $570.2 million in 2021, then plummeted by 32.01% to $387.7 million in 2022, then decreased by 8.49% to $354.8 million in 2023, then tumbled by 56.32% to $155.0 million in 2024, then slumped by 91.99% to $16.3 million in 2025.
- Its last three reported values are $16.3 million in Q3 2025, $40.8 million for Q2 2025, and $98.3 million during Q1 2025.